Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular tolerability of retinol palmitate ophthalmic gel vs carbomer in keratoconjunctivitis sicca
2006-000991-34Phase 4Active
- Sponsor
- Dr Gerhard Mann
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Vitagel in dry eye syndrome (DED) (2 arms), sponsored by Dr Gerhard Mann. Primary endpoint: Primary ocular tolerability over 12 months. Started Mar 2006; status: active.
02
Drugs
Vitagel
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2006-000991-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000991-34.